Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clara Bodelon

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Nature Medicine|November 27, 2023
A population-level digital histologic biomarker for enhanced prognosis of invasive breast cancerMohamed Amgad, James M Hodge, Maha A T Elsebaie, et al.
Environmental Research|May 6, 2023
In utero exposure to diethylstilbestrol and blood DNA methylation in adult women: Results from a meta-analysis of two cohort studiesClara Bodelon, Gretchen L Gierach, Elizabeth E Hatch, et al.
Breast Cancer Research and Treatment|August 15, 2024
Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ from 2001 to 2018Erin J Aiello Bowles, Cody Ramin, Jacqueline B Vo, et al.
Cancer Causes & Control : CCC|May 18, 2022
The influence of treatment on hormone receptor subgroups and breast cancer-specific mortality within US integrated healthcare systemsCody Ramin, Gretchen L Gierach, Mustapha Abubakar, et al.
Cancer Causes & Control : CCC|October 10, 2022
Correction to: The influence of treatment on hormone receptor subgroups and breast cancer-specific mortality within US integrated healthcare systemsCody Ramin, Gretchen L Gierach, Mustapha Abubakar, et al.
Breast Cancer Research : BCR|May 3, 2023
Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors CohortCody Ramin, Lene H S Veiga, Jacqueline B Vo, et al.
Breast Cancer Research and Treatment|March 11, 2022
Endocrine therapy initiation among women with stage I-III invasive, hormone receptor-positive breast cancer from 2001-2016Erin J Aiello Bowles, Cody Ramin, Diana S M Buist, et al.
BMC Cancer|November 1, 2015
Leukocyte telomere length and its association with mammographic density and proliferative diagnosis among women undergoing diagnostic image-guided breast biopsyClara Bodelon, Christopher M Heaphy, Alan K Meeker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival HeterogeneityClara Bodelon, J Keith Killian, Joshua N Sampson, et al.
The Lancet. Oncology|October 14, 2022
Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort studyLene H S Veiga, Jacqueline B Vo, Rochelle E Curtis, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Nature Medicine|November 27, 2023
A population-level digital histologic biomarker for enhanced prognosis of invasive breast cancerMohamed Amgad, James M Hodge, Maha A T Elsebaie, et al.
Environmental Research|May 6, 2023
In utero exposure to diethylstilbestrol and blood DNA methylation in adult women: Results from a meta-analysis of two cohort studiesClara Bodelon, Gretchen L Gierach, Elizabeth E Hatch, et al.
Breast Cancer Research and Treatment|August 15, 2024
Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ from 2001 to 2018Erin J Aiello Bowles, Cody Ramin, Jacqueline B Vo, et al.
Cancer Causes & Control : CCC|May 18, 2022
The influence of treatment on hormone receptor subgroups and breast cancer-specific mortality within US integrated healthcare systemsCody Ramin, Gretchen L Gierach, Mustapha Abubakar, et al.
Cancer Causes & Control : CCC|October 10, 2022
Correction to: The influence of treatment on hormone receptor subgroups and breast cancer-specific mortality within US integrated healthcare systemsCody Ramin, Gretchen L Gierach, Mustapha Abubakar, et al.
Breast Cancer Research : BCR|May 3, 2023
Risk of second primary cancer among women in the Kaiser Permanente Breast Cancer Survivors CohortCody Ramin, Lene H S Veiga, Jacqueline B Vo, et al.
Breast Cancer Research and Treatment|March 11, 2022
Endocrine therapy initiation among women with stage I-III invasive, hormone receptor-positive breast cancer from 2001-2016Erin J Aiello Bowles, Cody Ramin, Diana S M Buist, et al.
BMC Cancer|November 1, 2015
Leukocyte telomere length and its association with mammographic density and proliferative diagnosis among women undergoing diagnostic image-guided breast biopsyClara Bodelon, Christopher M Heaphy, Alan K Meeker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival HeterogeneityClara Bodelon, J Keith Killian, Joshua N Sampson, et al.
The Lancet. Oncology|October 14, 2022
Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort studyLene H S Veiga, Jacqueline B Vo, Rochelle E Curtis, et al.
Pageof 9